Patients with primary insulin resistance and impaired hepatic fat oxidation (common in MASLD) may respond more robustly to GLP-1 receptor agonists than those with intact metabolic flexibility the drug isn't just suppressing appetite, it's correcting a broken fuel switch
This article examines age-related eligibility criteria, safety considerations, NHS guidance, and alternative weight management options for older adults seeking these treatments
Currently, 25% of adults in the United Kingdom are living with obesity and the rise in obesity has significantly increased the number of patients with T2DM [4,5,6]
Individuals taking immunosuppressants or undergoing chemotherapy treatments, as glutathione may interfere with the intended effects of these medications
Target dehydration, fatigue, hangovers, and more with our tailored IV drips